FN2 Earnings Intelligence
Encompass Health Corporation income statement
Encompass Health Corporation (EHC) Income Statement (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $54.8 | $21.8 | $69.1 | $85.4 | $72.2 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $5,121.6 | $4,348.6 | $4,801.2 | $5,373.2 | $5,935.2 |
| % Growth | 10.3% | -15.1% | 10.4% | 11.9% | 10.5% |
| Gross Profit | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| EBITDA | - | $783.1 | - | - | - |
| % Margin | - | 18.0% | - | - | - |
| Net Income | $412.2 | $271 | $352 | $455.7 | $566.2 |
| % Margin | 8.0% | 6.2% | 7.3% | 8.5% | 9.5% |
| Diluted EPS | $4.11 | $2.70 | $3.47 | $4.46 | $5.54 |
| % Growth | 44.2% | -34.3% | 28.5% | 28.5% | 24.2% |
| Operating Cash Flow | $715.8 | $705.8 | $850.8 | $1,002.8 | $1,175.6 |
| CapEx | $528.9 | $564.8 | $583.1 | $642.5 | $736.4 |
| Free Cash Flow | $186.9 | $141 | $267.7 | $360.3 | $439.2 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue | $5,121.6 | $4,348.6 | $4,801.2 | $5,373.2 | $5,935.2 |
| Gross Profit | - | - | - | - | - |
| EBITDA | - | $783.1 | - | - | - |
| Net Income | $412.2 | $271 | $352 | $455.7 | $566.2 |
| Diluted EPS | $4.11 | $2.70 | $3.47 | $4.46 | $5.54 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $54.8 | $21.8 | $69.1 | $85.4 | $72.2 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $786.8 | $781.8 | $785 | $788.4 | $792 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $715.8 | $705.8 | $850.8 | $1,002.8 | $1,175.6 |
| Capital Expenditure | $528.9 | $564.8 | $583.1 | $642.5 | $736.4 |
| Free Cash Flow | $186.9 | $141 | $267.7 | $360.3 | $439.2 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 10.3% | -15.1% | 10.4% | 11.9% | 10.5% |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | - | 18.0% | - | - | - |
| Net Margin | 8.0% | 6.2% | 7.3% | 8.5% | 9.5% |
| FCF Margin | 3.6% | 3.2% | 5.6% | 6.7% | 7.4% |
| Diluted EPS Growth | 44.2% | -34.3% | 28.5% | 28.5% | 24.2% |
Get the EHC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.